3-methoxytyrosine has been researched along with Neurodevelopmental Disorders in 1 studies
Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rizzi, S | 1 |
| Spagnoli, C | 1 |
| Bellini, M | 1 |
| Cesaroni, CA | 1 |
| Spezia, E | 1 |
| Bergonzini, P | 1 |
| Caramaschi, E | 1 |
| Soliani, L | 1 |
| Turco, EC | 1 |
| Piccolo, B | 1 |
| Demuth, L | 1 |
| Cordelli, DM | 1 |
| Biasucci, G | 1 |
| Frattini, D | 1 |
| Fusco, C | 1 |
1 other study available for 3-methoxytyrosine and Neurodevelopmental Disorders
| Article | Year |
|---|---|
Aromatic L-Amino-Acid Decarboxylase Deficiency Screening by Analysis of 3-O-Methyldopa in Dried Blood Spots: Results of a Multicentric Study in Neurodevelopmental Disorders.
Topics: Carboxy-Lyases; Humans; Infant, Newborn; Malnutrition; Muscle Hypotonia; Neurodevelopmental Disorder | 2023 |